Literature DB >> 28684877

Immunotherapy: Keeping breast cancer in check.

Liesbet Lieben1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28684877     DOI： 10.1038/nrc.2017.55

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer.

Authors:  Emma Nolan; Peter Savas; Antonia N Policheni; Phillip K Darcy; François Vaillant; Christopher P Mintoff; Sathana Dushyanthen; Mariam Mansour; Jia-Min B Pang; Stephen B Fox; Charles M Perou; Jane E Visvader; Daniel H D Gray; Sherene Loi; Geoffrey J Lindeman
Journal:  Sci Transl Med       Date:  2017-06-07       Impact factor: 17.956
  1 in total
  3 in total

Review 1.  Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.

Authors:  Xiaohui Yan; Miao Qi; Pengfei Li; Yihong Zhan; Huanjie Shao
Journal:  Cell Biosci       Date:  2017-10-05       Impact factor: 7.133

Review 2.  Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer.

Authors:  Milad Ashrafizadeh; Mohammad Reza Bakhoda; Zahra Bahmanpour; Khandan Ilkhani; Ali Zarrabi; Pooyan Makvandi; Haroon Khan; Samaneh Mazaheri; Maryam Darvish; Hamed Mirzaei
Journal:  Front Chem       Date:  2020-10-15       Impact factor: 5.221

3.  ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.

Authors:  Jiazhou Liu; Yuxian Wei; Yushen Wu; Jie Li; Jiazheng Sun; Guosheng Ren; Hongzhong Li
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.